Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction ...

The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to ...